A fragmented, growth market in coronary stents

The size of the worldwide market for coronary stents, in the $billions, has created enormous incentive for manufacturers to develop and commercialize unique stent configurations that they hope to garner measureable share in this growth market.
 
As we have noted, the drug-eluting stent segment, with its success at producing minimally invasive revascularization of coronary stents well demonstrated in clinical trials that have yielded excellent clinical outcomes, has a flurry of new participants soon to introduce new DES products.
 
(See “Worldwide Coronary Stents Market, 2009-2013“.

Posted via email from medmarket’s posterous

Leave a Reply